Purified anti-Tau, 1-100 Antibody anti-Tau, 1-100 - 43D,BioLegend,816603

This antibody is reactive to amino acid residues 1-100 of human Tau. The epitope lies within amino acids 6-18. This clone is specific for all six isoforms of human tau protein.This antibody clone has been reported for use on IHC of 4% PFA-fixed free floating sections5.This antibody is exclusively provided by BioLegend.

Host

Mouse

Reactivity

Human

Application

WB -Quality testedIHC-P -Verified

Platform ID

BAB247404391

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-Tau, 1-100 Antibody anti-Tau, 1-100 - 43D
Cat. No.816603
HostMouse
RRIDAB_2715839 (BioLegend Cat. No. 816603)AB_2564800 (BioLegend Cat. No. 816601)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationWB -Quality testedIHC-P -Verified
ClonalityMonoclonal
Clone Number43D
Concentration2 mg/ml
TargetTau 1-100
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution.
StorageThis antibody should be handled aseptically as it is free of preservatives such as Sodium Azide. Store this antibody undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check the vial label orCoAto find the proper storage conditions.
Regulatory StatusResearch Use Only

Scientific Background

Tau protein promotes microtubule assembly and stability. Tau is abundant in neurons of the central nervous system, and is expressed at low levels in astrocytes and oligodendrocytes. Abnormal hyper-phosphorylation, aggregation, and toxic gain of function of tau is associated with several neurological disorders, including Alzheimer’s disease (AD). The major building block of neurofibrillary lesions in AD brains consists of paired helical filaments (PHFs) of abnormally hyperphosphorylated tau. Six isoforms of tau are generated by alternative splicing of the MAPT gene. These isoforms are distinguished by the number of tubulin binding domains, 3 (3R) or 4 (4R), in the C-terminal of the protein and by one (1N), two (2N), or no (0N) inserts in the N-terminal domain. Tau isoforms are differentially expressed during development.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.